Beijing Succeeder Technology Inc (688338) - Total Liabilities
Based on the latest financial reports, Beijing Succeeder Technology Inc (688338) has total liabilities worth CN¥69.11 Million CNY (≈ $10.11 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688338 financial resilience to evaluate the company's liquid asset resilience ratio.
Beijing Succeeder Technology Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how Beijing Succeeder Technology Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Beijing Succeeder Technology Inc (688338) total assets.
Beijing Succeeder Technology Inc Competitors by Total Liabilities
The table below lists competitors of Beijing Succeeder Technology Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GREENLIGHT CAP.RE A DL-01
F:G8L
|
Germany | €1.53 Billion |
|
Autolus Therapeutics Ltd
NASDAQ:AUTL
|
USA | $418.39 Million |
|
Zhanjiang Guolian Aquatic Products
SHE:300094
|
China | CN¥2.06 Billion |
|
Greenlight Capital Re Ltd
NASDAQ:GLRE
|
USA | $1.54 Billion |
|
Tectonic Therapeutic, Inc.
NASDAQ:TECX
|
USA | $16.16 Million |
|
LUBAWA SA
WAR:LBW
|
Poland | zł151.17 Million |
|
Ginkgo Bioworks Holdings
NYSE:DNA
|
USA | $569.76 Million |
|
Jiangsu Changqing Agrochemical Co Ltd
SHE:002391
|
China | CN¥4.86 Billion |
Liability Composition Analysis (2016–2025)
This chart breaks down Beijing Succeeder Technology Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Beijing Succeeder Technology Inc net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 20.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Succeeder Technology Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Succeeder Technology Inc (2016–2025)
The table below shows the annual total liabilities of Beijing Succeeder Technology Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥75.86 Million ≈ $11.10 Million |
-25.96% |
| 2024-12-31 | CN¥102.46 Million ≈ $14.99 Million |
-3.35% |
| 2023-12-31 | CN¥106.01 Million ≈ $15.51 Million |
-1.34% |
| 2022-12-31 | CN¥107.44 Million ≈ $15.72 Million |
+70.87% |
| 2021-12-31 | CN¥62.88 Million ≈ $9.20 Million |
+38.77% |
| 2020-12-31 | CN¥45.31 Million ≈ $6.63 Million |
-12.86% |
| 2019-12-31 | CN¥52.00 Million ≈ $7.61 Million |
+9.97% |
| 2018-12-31 | CN¥47.28 Million ≈ $6.92 Million |
+9.91% |
| 2017-12-31 | CN¥43.02 Million ≈ $6.29 Million |
-15.43% |
| 2016-12-31 | CN¥50.87 Million ≈ $7.44 Million |
-- |
About Beijing Succeeder Technology Inc
Beijing Succeeder Technology Inc. engages in the research, development, production, and sales of testing instruments, reagents, and consumables in the field of in vitro diagnostics for thrombosis and hemostasis in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation rate and hematocrit testers, platelet aggregation testers, blood rheol… Read more